Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
Researchers see sterile water, normal saline, and bacteriostatic water on the shelf and wonder if they are interchangeable
These different routes of administration provide flexibility in how the peptide can be used, making it suitable for a range of medical conditions and patient preferences
However, little is known about the precise effects of the two peptides when administered concurrently
Large doses may trigger hormonal changes or alter skin bacteria, leading to pimples or worsening of existing acne
Can BPC-157 and TB-500 be used together
